Corbus Pharmaceuticals
CRBP
#8614
Rank
HK$1.64 B
Marketcap
HK$88.92
Share price
-1.39%
Change (1 day)
50.65%
Change (1 year)

Market capitalization of Corbus Pharmaceuticals (CRBP)

Market cap: HK$1.64 Billion

As of May 2026 Corbus Pharmaceuticals has a market cap of HK$1.64 Billion. This makes Corbus Pharmaceuticals the world's 8614th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corbus Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.64 B44.81%
2025HK$1.13 B-5.63%
2024HK$1.20 B477.73%
2023HK$0.20 B92.93%
2022HK$0.10 B-82.01%
2021HK$0.60 B-26.17%
2020HK$0.81 B-70.39%
2019HK$2.75 B5.04%
2018HK$2.61 B-15.07%
2017HK$3.08 B5.87%
2016HK$2.91 B505.47%
2015HK$0.48 B-20.05%
2014HK$0.60 B

End of Day market cap according to different sources

On May 21st, 2026 the market cap of Corbus Pharmaceuticals was reported to be:

HK$1.67 Billion
by Nasdaq info icon info icon
HK$1.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Viking Therapeutics
VKTX
HK$28.09 B 1,605.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
HK$2.91 B 77.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
HK$1.93 B 17.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
HK$10.01 M-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA